The efficacy of smoking cessation therapies in cardiac patients: A meta-analysis of randomized controlled trials

Canadian Journal of Cardiology

Volumn 26, Issue 2, 2010, Pages 73-79

  Eisenberg, Mark J ^a,b   Blum, Lisa M ^a   Filion, Kristian B ^a,b,c   Rinfret, Stephane ^d   Pilote, Louise ^b,c   Paradis, Gilles ^b   Joseph, Lawrence ^b,c   Gervais, André ^e   O'Loughlin, Jennifer ^d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e Gouvernement du Quebec   (Canada)

Author keywords

Behavioural therapy; Cardiac patients; Smoking cessation; Smoking cessation pharmacotherapy

Indexed keywords

AMFEBUTAMONE; NICOTINE GUM; NICOTINE PATCH; ANTIDEPRESSANT AGENT;

ARTICLE; BEHAVIOR THERAPY; CARDIAC PATIENT; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEART DISEASE; HUMAN; MEDICAL LITERATURE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; CARDIOVASCULAR DISEASE; METHODOLOGY; REVIEW; SMOKING;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR THERAPY; BUPROPION; CARDIOVASCULAR DISEASES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 77949329404     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(10)70002-7     Document Type: Article

References (42)

1. Ockene J, Kristeller JL, Goldberg R, et al. Smoking cessation and severity of disease: The Coronary Artery Smoking Intervention Study. Health Psychol 1992;11:119-126
2. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy. J Am Coll Cardiol 1997;29:1422-1431 (Pubitemid 27272432)
3. Samet JM. The 1990 Report of the Surgeon General: The Health Benefits of Smoking Cessation. Am Rev Respir Dis 1990;142:993-994
4. Reducing tobacco use: A report of the Surgeon General - executive summary. Nicotine Tob Res 2000;2:379-395
5. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999;340:685-691
6. Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR; for the Varenicline Phase. Effect of maintenance therapy with varenicline on smoking cessation: A randomized controlled trial. JAMA 2006;296:64-71.
7. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004:CD000146.
8. Hays JT, Hurt RD, Rigotti NA, et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: A randomized, controlled trial. Ann Intern Med 2001;135:423-433
9. Hurt RD, Sachs DPL, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997;337:1195-1202
10. Wilkes S, Evans A. A cross-sectional study comparing the motivation for smoking cessation in apparently healthy patients who smoke to those who smoke and have ischaemic heart disease, hypertension or diabetes. Fam Pract 1999;16:608-610 (Pubitemid 30000178)
11. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. The Lancet 1999;354:1896-1900
12. Bolman C, de Vries H, van Breukelen G. A minimal-contact intervention for cardiac inpatients: Long-term effects on smoking cessation. Prev Med 2002;35:181-192
13. Burt A, Thornley P, Illingworth D, White P, Shaw TR, Turner R. Stopping smoking after myocardial infarction. Lancet 1974;1:304-306
14. Johnson JL, Budz B, Mackay M, Miller C. Evaluation of a nurse-delivered smoking cessation intervention for hospitalized patients with cardiac disease. Heart Lung 1999;28:55-64. (Pubitemid 29055084)
15. Pozen MW, Stechmiller JA, Harris W, Smith S, Fried DD, Voigt GC. Nurse rehabilitators impact on patients with myocardial-infarction. Med Care 1977;15:830-837 (Pubitemid 8203305)
16. Haskell WL, Alderman EL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994;89:975-990
17. Wewers ME, Bowen JM, Stanislaw AE, Desimone VB. A nurse-delivered smoking cessation intervention among hospitalized postoperative patients - influence of a smoking-related diagnosis: A pilot study. Heart Lung 1994;23:151-156
18. Hajek P, Taylor TZ, Mills P. Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: Randomised controlled trial. BMJ 2002;324:87-89 (Pubitemid 34073139)
19. DeBusk RF, Miller NH, Superko HR, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med 1994;120:721-729 (Pubitemid 24125291)
20. Quist-Paulsen P, Gallefoss F. Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease. BMJ 2003;327:1254-1257 (Pubitemid 37487281)
21. Feeney GF, McPherson A, Connor JP, McAlister A, Young MR, Garrahy P. Randomized controlled trial of two cigarette quit programmes in coronary care patients after acute myocardial infarction. Intern Med J 2001;31:470-475
22. Taylor CB, Houston-Miller N, Killen JD, Debusk RF. Smoking cessation after acute myocardial infarction: Effects of a nurse-managed intervention. Ann Intern Med 1990;113:118-123 (Pubitemid 20218629)
23. Rigotti NA, McKool KM, Shiffman S. Predictors of smoking cessation after coronary artery bypass graft surgery: Results of a randomized trial with 5-year follow-up. Ann Intern Med 1994;120:287-293 (Pubitemid 24050024)
24. Miller NH, Smith PM, Debusk RF, Sobel DS, Taylor CB. Smoking cessation in hospitalized patients - results of a randomized trial. Arch Intern Med 1997;157:409-415 (Pubitemid 27089966)
25. Carlsson R, Lindberg G, Westin L, Israelsson B. Influence of coronary nursing management follow up on lifestyle after acute myocardial infarction. Heart 1997;77:256-259 (Pubitemid 27122779)
26. Engblom E, Ronnemaa T, Hamalainen H, Kallio V, Vanttinen E, Knuts LR. Coronary heart disease risk factors before and after bypass surgery: Results of a controlled trial on multifactorial rehabilitation. Eur Heart J 1992;13:232-237
27. Dornelas EA, Sampson RA, Gray JF, Waters D, Thompson PD. A randomized controlled trial of smoking cessation counseling after myocardial infarction. Prev Med 2000;30:261-268 (Pubitemid 30211083)
28. Tzivoni D, Keren A, Meyler S, Khoury Z, Lerer T, Brunel P. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther 1998;12:239-244 (Pubitemid 28416489)
29. Rennard S, Daughton D, Cheney R, et al. Nicotine replacement therapy for patients with coronary-artery disease. Arch Intern Med 1994;154:989-995 (Pubitemid 24144874)
30. Tonstad S, Farsang C, Klaene G, et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: A multicentre, randomised study. Eur Heart J 2003;24:946-955 (Pubitemid 36559988)
31. Rigotti NA, Thorndike AN, Regan S, et al. Bupropion for smokers hospitalized with acute cardiovascular disease. Am J Med 2006;119:1080-1087 (Pubitemid 44834365)
32. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335:1792-1798
33. Hughes JR, Goldstein MG, Hurt RD, Shiffman S. Recent advances in the pharmacotherapy of smoking. JAMA 1999;281:72-76
34. Simon JA, Carmody TP, Hudes ES, Snyder E, Murray J. Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: A randomized trial. Am J Med 2003;114:555-562 (Pubitemid 36577258)
35. The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. JAMA 1996;275:1270-1280 (Pubitemid 26118502)
36. Campbell IA, Prescott RJ, Tjeder-Burton SM. Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum. Respir Med 1991;85:155-157
37. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: The case of smoking cessation. Health Educ Res 2003;18:156-170
38. Freund KM, D'Agostino RB, Belanger AJ, Kannel WB, Stokes J III. Predictors of smoking sessation: The Framingham Study. Am J Epidemiol 1992;135:957-964
39. Stern JM, Simes RJ. Publication bias: Evidence of delayed publication in a cohort study of clinical research projects. BMJ 1997;315:640-645
40. Jorenby DE, Hays JT, Rigotti NA, et al; for the Varenicline Phase. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. JAMA 2006;296:56-63.
41. O'Brien CP. Anticraving medications for relapse prevention: A possible new class of psychoactive medications. Am J Psychiatry 2005;162:1423-1431
42. Cornuz J, Klingler K, Mueller P, Jungi F, Cerny T. A therapeutic vaccine for nicotine dependence: Results of a phase I and a randomized phase II study. J Clin Oncol 200;23(16 Suppl):1008. (Abst)